Echo launches trial to help it obtain CE mark for Symphony device

06/6/2013 | (Boston)

Echo Therapeutics has initiated a multicenter clinical study of its Symphony system, a wireless device that can monitor glucose continuously in a noninvasive manner. The study, which will involve 32 critically ill patients from four hospitals in the U.S., could help pave the way for CE mark approval of the transdermal device in Europe.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO